Tongmai Yangxin pill alleviates myocardial no-reflow by activating GPER to regulate HIF-1α signaling and downstream potassium channels
AbstractContext The Tongmai Yangxin pill (TMYX) has potential clinical effects on no-reflow (NR); however, the effective substances and mechanisms remain unclear.Objective This study evaluates the cardioprotective effects and molecular mechanisms of TMYX against NR.Materials and methods We used a my...
Gardado en:
Main Authors: | , , , , , , |
---|---|
Formato: | Libro |
Publicado: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Acceso en liña: | Connect to this object online. |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Internet
Connect to this object online.3rd Floor Main Library
Número de Clasificación: |
A1234.567 |
---|---|
Copia 1 | Dispoñible |